AXGN stock

Axogen Inc (AXGN) support and resistance · rev $131.2M

Axogen Inc (AXGN) is a medical devices company listed on US.

This page maps Axogen Inc (AXGN) support and resistance from cached range and valuation — not a live tape and not a trade alert.

Latest reported AXGN revenue for 2026-06-30 was $131.2M. Net income was -$21.1M. AXGN currently screens at market cap $497.8M.

AXGN currently screens at market cap $497.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.

A new AXGN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.

Not investment advice. Use the AXGN quote page for the session range and the stock page for the full model.

Not investment advice.

Full AXGN analysis